Autopsy report · NCT00962273

The Pandemic Stress Vaccine: A Resource to Enhance the Resilience of Healthcare Workers Facing an Infectious Outbreak

“low participation and retention rates”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 months before it started.
• Ran for about 9 months before it stopped.
• 118 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

Mount Sinai Hospital, Canada

Sponsor type

University, hospital or other

Conditions

Psychological Stress

Interventions

Interactive computerized learning resource; Didactic computerized learning resource

Participants

118

Sites

1

Countries

Canada

Trials that died the same way

• Supplementation With Polyphenol-Rich Foods and Atrial Fibrillation After a Cardiac Surgery
  “low participation rate” (78% match in meaning)
• Prospective Study of TW in Treatment of IgAN With Asymptomatic Abnormal Urinalysis
  “low-rate of enrollment” (67% match in meaning)
• Physiotherapy and Therapeutic Education After Total Knee Arthroplasty.
  “low participation” (67% match in meaning)
• Erenumab-aooe for the Management of Trigeminal Neuropathic Pain.
  “Low enrollment rate” (65% match in meaning)
• StepRite Evaluation
  “Recruitment and retention difficulties” (65% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.